ChemBriefAbbott Results Beat on Medical Device Boost, Exact Sciences Deal Hits Forecast
Abbott exceeded quarterly profit and revenue expectations driven by its medical device unit, though shares fell after lowering its 2026 profit forecast by 20 cents per share due to the $23 billion Exa
reuters · 2026-04-16 04:33